<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51511">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02435602</url>
  </required_header>
  <id_info>
    <org_study_id>506-1-09-01-14</org_study_id>
    <nct_id>NCT02435602</nct_id>
  </id_info>
  <brief_title>The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers</brief_title>
  <official_title>The Role of Narrow Band Imaging (NBI) Endoscopy Compared With Lugol Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers: a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre of Postgraduate Medical Education</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the role of narrow band imaging (NBI) endoscopy compared with Lugol
      chromoendoscopy in the early detection of esophageal cancer in patients with prior head and
      neck cancers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with head and neck cancers have an increased risk for developing an esophageal
      squamous cell carcinoma (ESCC). Small, superficial, curable lesions are difficult to
      diagnose using only white light endoscopy. To improve detection chromoendoscopy is
      recommended. In this project patients are divided into two groups based on received
      chromoendoscopy (NBI versus Lugol). The results of two methods will be compare regarding
      positive predictive value to establish usage of chromoendoscopy in early detection of ESCC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive predictive value</measure>
    <time_frame>2 years</time_frame>
    <description>The results of two methods are compare regarding positive predictive value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of the esophagoscopy ( NBI versus Lugol staining)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of endoscopy ( NBI versus Lugol staining) tolerance using Visual Analogue Scale (VAS)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Esophageal Squamous Cell Carcinoma</condition>
  <condition>Squamous Cell Carcinoma of the Head and Neck</condition>
  <arm_group>
    <arm_group_label>NBI endoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GI endoscopy examination and additional the entire length of esophagus is evaluate with NBI endoscopy
Biopsy at the visually abnormal lesions
Pathologic examination of all biopsy tissue specimens
Advises of endoscopic/surgical or oncological treatment will be given to participants who will be diagnosed with ESCC or high grade dysplasia of the esophagus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lugol chromoendoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GI endoscopy examination and additional the entire length of esophagus is evaluate with Lugol chromoendoscopy
Biopsy at the unstained lesions &gt;= 5 mm diameter
Pathologic examination of all biopsy tissue specimens
Advises of endoscopic/surgical or oncological treatment will be given to participants who will be diagnosed with ESCC or high grade dysplasia of the esophagus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NBI endoscopy</intervention_name>
    <description>GI endoscopy examination and additional the entire length of esophagus is evaluate with NBI endoscopy Biopsy at the visually abnormal lesions</description>
    <arm_group_label>NBI endoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lugol chromoendoscopy</intervention_name>
    <description>GI endoscopy examination and additional the entire length of esophagus is evaluate with Lugol chromoendoscopy Biopsy at the unstained lesions &gt;= 5 mm diameter Pathologic examination of all biopsy tissue specimens</description>
    <arm_group_label>lugol chromoendoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with past history ( &gt;= 1 year ) of head and neck cancer treated curatively
             and receiving regular follow - up at the outpatient clinic of the Head and Neck
             Department of Maria Sk≈Çodowska - Curie Memorial Cancer Center, Institiut of Oncology

          -  18 years and older

          -  Diagnosis of squamous cell carcinoma of oral cavity, oropharynx, hypopharynx, larynx

          -  Zubrod scale 0-2

          -  Provided written informed consent

        Exclusion Criteria:

          -  Lack of written informed consent

          -  Known allergy to iodine

          -  Clinical conditions precluding upper GI endoscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaroslaw Regula, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Maria Sklodowska-Curie Memorial Cancer Center, Institiute of Oncology, Warsaw, Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Chaber-Ciopinska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maria Sklodowska-Curie Memorial Cancer Center, Institiute of Oncology, Warsaw, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Chaber-Ciopinska, MD</last_name>
    <phone>+48606608762</phone>
    <email>annachaber@op.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jaroslaw Regula, PhD</last_name>
    <phone>+48225463044</phone>
    <email>jregula@coi.waw.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maria Sklodowska-curie Memorial Cancer Center, Institiute of Oncology</name>
      <address>
        <city>Warsaw</city>
        <zip>02-781</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Chaber-Ciopinska, MD</last_name>
      <phone>+48606608762</phone>
      <email>annachaber@op.pl</email>
    </contact>
    <contact_backup>
      <last_name>Jaroslaw Regula, PhD</last_name>
      <phone>+48225463044</phone>
      <email>jregula@coi.waw.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <lastchanged_date>May 5, 2015</lastchanged_date>
  <firstreceived_date>May 1, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endoscopy, gastrointestinal</keyword>
  <keyword>cancer screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lugol's solution</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
